NeuroOne® Announces Expansion of Existing Distribution Agreement with Zimmer Biomet for Commercialization of OneRF™ Ablation System
31. Oktober 2024 16:01 ET
|
NeuroOne Medical Technologies Corp
License Provides Exclusive Commercialization Rights for US Distribution and Certain OUS MarketsAgreement expected to boost NeuroOne sales revenue and profitability EDEN PRAIRIE, Minn., Oct. 31,...
NeuroOne® Spinal Cord Stimulation Electrode Technology to be Featured at The Business of Pain Conference
24. September 2024 09:30 ET
|
NeuroOne Medical Technologies Corp
Minimally invasive technology would allow for percutaneous placement of a paddle electrode Renowned pain specialist Dr. Sean Li to present on this innovative tool for lower back pain EDEN PRAIRIE,...
NeuroOne® Announces Breakthrough Case Completed with OneRF™ Ablation System at the University Hospitals in Cleveland
10. September 2024 09:00 ET
|
NeuroOne Medical Technologies Corp
Forty-four ablations performed successfully in one patient Patient currently reportedly seizure free with improvements in mood and memory EDEN PRAIRIE, Minn., Sept. 10, 2024 (GLOBE NEWSWIRE)...
NeuroOne® to Present at the H.C. Wainwright 26th Annual Global Investment Conference
05. September 2024 18:23 ET
|
NeuroOne Medical Technologies Corp
EDEN PRAIRIE, Minn., Sept. 05, 2024 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) (“NeuroOne” or the “Company”), a medical technology company focused on improving...
NeuroOne® Reports Third Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update
14. August 2024 16:00 ET
|
NeuroOne Medical Technologies Corp
EDEN PRAIRIE, Minn., Aug. 14, 2024 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) (“NeuroOne” or the “Company”), a medical technology company focused on improving...
NeuroOne® to Report Third Quarter Fiscal Year 2024 Financial Results and Provide Corporate Update on August 14
12. August 2024 11:30 ET
|
NeuroOne Medical Technologies Corp
EDEN PRAIRIE, Minn., Aug. 12, 2024 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving...
NeuroOne® Announces $2.65 Million Equity Financing And $3.0 Million Credit Facility
05. August 2024 09:00 ET
|
NeuroOne Medical Technologies Corp
Proceeds to be used for OneRF commercialization activities and to bridge the Company to the close of a potential distribution arrangement with a strategic partner currently in the diligence process ...
NeuroOne® Announces First in Human Ablations Completed with OneRF™ Ablation System
25. Juni 2024 09:00 ET
|
NeuroOne Medical Technologies Corp
Five ablations performed successfully in one patient Procedure performed at patient’s bedside saving time and cost associated with the operating room EDEN PRAIRIE, Minn., June 25, 2024 (GLOBE...
NeuroOne® Granted Approval of ICD-10 Procedure Code for sEEG RF Ablation
20. Juni 2024 09:30 ET
|
NeuroOne Medical Technologies Corp
ICD-10-PCS code for first to market, FDA-cleared thin-film, sEEG-guided RF ablation system effective October 1, 2024 Specific procedure code positions OneRF™ Ablation System for broader adoption and...
NeuroOne® Reports Second Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update
14. Mai 2024 16:00 ET
|
NeuroOne Medical Technologies Corp
EDEN PRAIRIE, Minn., May 14, 2024 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) (“NeuroOne” or the “Company”), a medical technology company focused on improving...